ReadeRx Therapeutics Overview
ReadeRx is developing small molecule inhibitors targeting the RNA binding protein IGF2BP1 as a novel treatment for cancer. IGF2BP1 is an oncofetal RNA binding protein expressed in many types of cancers. it regulates RNA function at many levels, including intracellular RNA localization, RNA stability, and translational control. IGFB2P1 is widely expressed in development but is dramatically reduced in normal mature tissues. In many cancers IFG2BP1 is reactivated, assuming a pivotal role in stabilizing key pro-oncogenic RNAs, thereby promoting pro-oncogenic and pro-tumorigenic processes. Consequently, the inhibition of IGF2BP1 emerges as a highly promising strategy for cancer therapy.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | www.futurx.co.il/portfolio/readerx-therapeutics/ |
Locations
Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
ReadeRx Therapeutics Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsMoleculesTags (4)
oncologypharmaceuticalscancer-therapycancerReadeRx Therapeutics Financials
ReadeRx Therapeutics Lifecycle
ReadeRx Therapeutics News
0 articlesNo news articles.
ReadeRx Therapeutics Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 4 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
ReadeRx Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 78/100 |
| Missing | sector, video or image, funding rounds, news, markets, external profiles, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516752490 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-11-15T00:00:00.000Z |
| Created | 2023-11-15T00:00:00.000Z |